Oocyte Donation, Gestational Carriers, and Adoption for Breast Cancer Survivors
| Autor: | Divya K. Shah, Iris Tienlynn Lee, Leigh A. Humphries |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Pregnancy Assisted reproductive technology business.industry Offspring Obstetrics medicine.medical_treatment Context (language use) medicine.disease 03 medical and health sciences Gestational carrier 0302 clinical medicine Breast cancer Oncology Surgical oncology 030220 oncology & carcinogenesis Oocyte donation medicine 030212 general & internal medicine business |
| Zdroj: | Current Breast Cancer Reports. 12:361-366 |
| ISSN: | 1943-4596 1943-4588 |
| DOI: | 10.1007/s12609-020-00391-y |
| Popis: | The purpose of this review is to describe and compare the use of oocyte donation, gestational carriers, and adoption for family building specifically in women with a history of breast cancer. Oocyte donation is an effective and safe option for women whose exposure to gonadotoxic cancer therapy has resulted in primary ovarian insufficiency, or for women with a familial cancer syndrome who are concerned about genetic risk to their offspring. A gestational carrier may also be considered—with or without oocyte donation—depending on the patient’s acceptance of ovarian stimulation and pregnancy in the context of prior breast cancer or ongoing endocrine therapy. Lastly, adoption is a frequently considered option for family building by many breast cancer survivors. Assisted reproductive technology and adoption offer breast cancer survivors the opportunity to expand their families despite the challenges that the diagnosis may pose. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink